Table 3.
Effect of telemonitoring and/or telerehabilitation on health-related quality of life and/or health status in patients with lung diseases or COVID-19.
| Disease | Study | Health-related quality of life (HRQoL) and/or health status | |||
|---|---|---|---|---|---|
| IG change from pre-intervention | IG effect in comparison with CG | Instrument/tool used to assess the outcome | |||
| Telemonitoring | Asthma | Rasmussen, L. 2005 58 | ↑ | ↑ (than the 2 CGs) | Asthma-related quality of life (AQLQ) |
| van Gaalen, J. 2013 61 | ↑ | ↑ | AQLQ | ||
| Zairina, E. 2015 63 | ↑ | ↑ | mAQLQ (mini asthma quality of life questionnaire) | ||
| de Jongste, J. 2009 45 | ↑ | = | Pediatric asthma caregiver quality of life questionnaire (PACQLQ) | ||
| Chan, D. 2007 42 | ↑ | NR | Pediatric asthma quality of life questionnaires (PAQLQ) applied to caregiver | ||
| COPD and/or asthma | Cushen, B. 2021 44 | no | NA | EQ-VAS questionnaire | |
| COPD | Koff, P. 2021 51 | ↑ | ↑ | SGRQ | |
| Farmer, A. 2017 49 | ↑ | ↑ | EQ-5D-5L questionnaire | ||
| ↑ | = | SGRQ | |||
| Stamenova, V. 2020 60 | ↑ | = (in the 3 groups) | SGRQ | ||
| Deng, N. 2020 46 | ↑ | NA | COPD assessment test (CAT) | ||
| Antoniades, N. 2012 39 | no | = | Chronic respiratory disease questionnaire (CRDQ), 36-Item short from survey (SF-36) | ||
| Persson, H. 2020 56 | no | NA | SGRQ | ||
| McDowell, J. 2015 53 | NR | ↑ | SGRQ | ||
| = | EQ-5D questionnaire | ||||
| Boer, L. 2019 41 | NR | = | EQ-5D questionnaire, Nijmegen clinical screening instrument (NSCI), Clinical COPD Questionnaire (CCQ) | ||
| Chau, J. 2012 43 | NR | = | Chronic respiratory questionnaire (CRQ) | ||
| Jódar-Sánchez, F. 2013 50 | NR | = | SGRQ, EuroQoL-5D questionnaire | ||
| Lewis, K. 2010 69 | NR | = | SGRQ, and EuroQoL EQ-5D questionnaire | ||
| Pinnock, H. 2013 57 | NR | = | SGRQ | ||
| Schou, L. 2013 59 | NR | = | SGRQ | ||
| Vianello, A. 2016 62 | NR | = | SF-36 | ||
| Telerehabilitation | COPD | Stickland, M. 2011 70 | ↑ | = | SGRQ |
| Burkow, T. 2015 65 | ↑ | NA | SGRQ | ||
| Lewis, A. 2021 69 | ↑ | NA | CRQ | ||
| Rassouli, F. 2018 79 | ↑ | NA | CAT, CRQ | ||
| Jiang, Y. 2020 67 | ↑ | = | CAT, SGRQ | ||
| Jiménez-Reguera, B. 2020 68 | ↑ | = | SGRQ | ||
| no | = | CAT, EuroQOL-5D questionnaire | |||
| Hansen, H. 2020 66 | ↑ | = | Clinical COPD Questionnaire (CCQ) | ||
| no | = | EQ-5D-VAS | |||
| Telerehabilitation and telemonitoring | COVID-19 | Gilmutdinova, I. 2021 75 | ↑ | NA | Survey (Overall well-being improved in 83% of the participants) |
| COPD | Holland, A. 2013 76 | ↑ | NA | CRQ | |
| Marquis, N. 2015 77 | ↑ | NA | CRQ | ||
| Paneroni, M. 2015 78 | ↑ | = | SGRQ | ||
| Tsai, L. 2017 81 | ↑ | = | CAT | ||
| no | = | CRDQ (Chronic respiratory disease Questionnaire) | |||
| Benzo, R. 2021 71 | NR | = | CRQ | ||
| Broadbent, E. 2018 73 | NR | = | CCQ | ||
| Galdiz, J. 2020 74 | no | = | SF-36, Chronic respiratory disease Questionnaire (CRQ) | ||
IG: Intervention group; CG: control group. NA: not applicable. EQ-VAS: EuroQol-visual analogue scales; CAT: COPD assessment test; SGRQ: St George's Respiratory Questionnaire; CRQ: chronic respiratory disease questionnaire; ↑: significantly better outcome; =: no significant difference in outcome change between groups. NR: data and/or significance level not reported.